Skip to content

Predicting Efficacy on Acute Ischemic Stroke by Artificial Intelligence: a case records based study

A case records based study of Predicting Efficacy of Mechanical Thrombectomy on Acute Ischemic Stroke by Artificial Intelligence

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800017169
Enrollment
Unknown
Registered
2018-07-16
Start date
2018-07-03
Completion date
Unknown
Last updated
2018-07-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Ischemic Stroke

Interventions

Gold Standard:NIHSS
Index test:artificial&#32
intelligence&#32

Sponsors

The Second Institute of Clinical Medicine,Guangzhou University of Chinese Medicine(Guangdong Provincial Hospital of Chinese Medicine)
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 96 Years

Inclusion criteria

Inclusion criteria: 1. According to the American Stroke Management Guide in 2018, patients diagnosed with acute ischemic stroke. 2. The patient's had received MRI(T1, T2, DWI, ADC) examination within 5 hours before treatment and determined the presence of "ischemic penumbra" with DWI and T2Flair mismatch. 3. The patient's had received CT scan of the head before treatment to exclude patients with cerebral hemorrhage 4. From symptom onset to treatment no more than 24 hours. 5. CT examination was performed within 12 hours after surgery,NIHSS scores were checked 5 days after treatment and one month after discharge.

Exclusion criteria

Exclusion criteria: (1) A history of intracranial hemorrhage in the last 3 weeks, cerebral arteriovenous stenosis or aneurysm was found previously and without intervention or surgery; (2) Uncontrollable refractory hypertension (systolic blood pressure=185mmHg, or diastolic blood pressure=110mmHg); (3) known to be allergic to contrast agents; (4) blood glucose 22.0mmmol / L; (5) Acute hemorrhagic constitution, including clotting factor deficiency, international normalized ratio (INR) > 1.7 or platelet count < 100 x 10^9/L; (6) Had history of arterial puncture in incompressible areas within the last 7 days; Major surgery or severe trauma history in the last 14 days; Gastrointestinal or urethral bleeding in the last 21 days. (7) Had diseases that increase the risk of bleeding in the last 3 months, such as severe craniocerebral trauma, severe liver disease, ulcerative gastrointestinal disease, etc.Had surgery, substantial organ biopsy, active bleeding within 1 month; (8) Suspected septic embolism or bacterial endocarditis; (9) Life expectancy <90 days.

Design outcomes

Primary

MeasureTime frame
Accuracy;Sensitivity;

Countries

China

Contacts

Public ContactGuo-qing Liu, Bo Liu

The Second Institute of Clinical Medicine, Guangzhou University of Chinese Medicine(Guangdong Provincial Hospital of Chinese Medicine)

liugq01@hotmail.com+86 13560348769

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026